• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    11/29/22 11:04:38 AM ET
    $NAII
    $NBRV
    $NCPL
    $NHWK
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $NAII alert in real time by email

     

    On Tuesday, 89 companies set new 52-week lows.

    Noteable 52-Week Lows:

    • The largest company in terms of market cap to set a new 52-week low was Lucid Gr (NASDAQ:LCID).
    • Infobird Co (NASDAQ:IFBD) was the smallest, in terms of market cap, to set a new 52-week low.
    • CNS Pharmaceuticals (NASDAQ:CNSP) saw the most pronounced move, as shares traded down 2455.54% to hit its new 52-week low.
    • Lilium (NASDAQ:LILM)'s stock showed potential to rebound, rebounding up 0.0% after reaching a new 52-week low.

    On Tuesday, the following stocks broke to new 52-week lows:

    • Lucid Gr (NASDAQ:LCID) shares reached a new 52-week low of $9.80 on Tuesday morning, moving down 0.3%.
    • Credit Suisse Group (NYSE:CS) shares fell to $3.22 on Tuesday, setting a new 52-week low with a shift of down 2.52%.
    • Lumen Technologies (NYSE:LUMN) shares fell to $5.40 on Tuesday, setting a new 52-week low with a shift of down 1.81%.
    • Lumentum Holdings (NASDAQ:LITE) shares were down 0.83% for the day, having made a 52-week low of $53.79.
    • ZIM Integrated Shipping (NYSE:ZIM) shares moved up 3.9% on Tuesday to hit a new 52-week low of $20.82, drifting up 3.9%.
    • United States Cellular (NYSE:USM) stock hit a yearly low of $19.89. The stock was up 0.81% for the day.
    • Brookfield Business (NYSE:BBUC) stock hit a yearly low of $20.76. The stock was down 1.03% for the day.
    • Aurora Innovation (NASDAQ:AUR) shares were up 2.4% for the day, having made a 52-week low of $1.22.
    • Grindr (NYSE:GRND) shares made a new 52-week low of $7.60 on Tuesday. The stock was down 4.11% for the day.
    • Brookfield Bus (NYSE:BBU) shares hit a yearly low of $18.39. The stock was up 0.14% on the session.
    • Apollo Medical Hlgs (NASDAQ:AMEH) stock drifted down 0.5% on Tuesday morning to hit a new 52-week low of $27.33.
    • Telephone and Data (NYSE:TDS) shares moved up 1.37% on Tuesday to hit a new 52-week low of $9.66, drifting up 1.37%.
    • Oatly Group (NASDAQ:OTLY) stock hit a new 52-week low of $1.57. The stock was up 0.63% on the session.
    • Nextdoor Holdings (NYSE:KIND) shares hit a yearly low of $2.02. The stock was up 1.21% on the session.
    • NewAmsterdam Pharma (NASDAQ:NAMS) shares made a new 52-week low of $8.11 on Tuesday. The stock was down 6.18% for the day.
    • Cerence (NASDAQ:CRNC) shares hit a yearly low of $12.82. The stock was up 16.67% on the session.
    • BrightView Holdings (NYSE:BV) shares reached a new 52-week low of $6.71 on Tuesday morning, moving down 2.87%.
    • Scilex Holding (NASDAQ:SCLX) shares made a new 52-week low of $4.01 on Tuesday. The stock was up 2.56% for the day.
    • Emergent BioSolutions (NYSE:EBS) shares set a new yearly low of $11.51 this morning. The stock was up 1.29% on the session.
    • AMC Entertainment (NYSE:APE) stock hit $1.08 on Tuesday morning, setting a new 52-week low for a change of down 4.82%.
    • Snap One Holdings (NASDAQ:SNPO) shares set a new yearly low of $7.26 this morning. The stock was down 2.01% on the session.
    • Lilium (NASDAQ:LILM) stock drifted 0.0% (flat) on Tuesday morning to hit a new 52-week low of $1.38.
    • Phibro Animal Health (NASDAQ:PAHC) shares reached a new 52-week low of $11.82 on Tuesday morning, moving down 2.23%.
    • Blend Labs (NYSE:BLND) stock achieved a new 52-week low on Tuesday morning, hitting $1.19 and moving down 4.37%.
    • ADC Therapeutics (NYSE:ADCT) stock achieved a new 52-week low on Tuesday morning, hitting $3.31 and moving up 1.03%.
    • Sify Technologies (NASDAQ:SIFY) shares moved down 2.1% on Tuesday to hit a new 52-week low of $1.39, drifting down 2.1%.
    • Invivyd (NASDAQ:IVVD) shares were up 1.86% for the day, having made a 52-week low of $2.08.
    • Markforged Holding (NYSE:MKFG) shares moved up 0.43% on Tuesday to hit a new 52-week low of $1.14, drifting up 0.43%.
    • Motorcar Parts of America (NASDAQ:MPAA) stock dropped to a yearly low on Tuesday of $11.39. Shares traded down 3.01%.
    • Berkshire Grey (NASDAQ:BGRY) shares were up 0.06% for the day, having made a 52-week low of $0.91.
    • Cango (NYSE:CANG) shares hit a yearly low of $1.52. The stock was up 0.65% on the session.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) stock achieved a new 52-week low on Tuesday morning, hitting $4.51 and moving down 0.87%.
    • Instil Bio (NASDAQ:TIL) stock dropped to a yearly low on Tuesday of $1.32. Shares traded down 0.74%.
    • Sarcos Technology (NASDAQ:STRC) stock set a new 52-week low of $1.02 on Tuesday, moving down 0.93%.
    • Inseego (NASDAQ:INSG) shares fell to $1.25 on Tuesday, setting a new 52-week low with a shift of up 0.78%.
    • Relmada Therapeutics (NASDAQ:RLMD) shares moved down 5.71% on Tuesday to hit a new 52-week low of $4.62, drifting down 5.71%.
    • Tempo Automation Holdings (NASDAQ:TMPO) shares reached a new 52-week low of $5.02 on Tuesday morning, moving down 3.59%.
    • Redwire (NYSE:RDW) shares hit a yearly low of $2.10. The stock was down 2.22% on the session.
    • Tattooed Chef (NASDAQ:TTCF) shares set a new yearly low of $1.44 this morning. The stock was up 3.02% on the session.
    • Xos (NASDAQ:XOS) stock drifted down 1.42% on Tuesday morning to hit a new 52-week low of $0.72.
    • Provident Bancorp (NASDAQ:PVBC) stock achieved a new 52-week low on Tuesday morning, hitting $6.64 and moving up 2.5%.
    • Grove Collaborative Hldgs (NYSE:GROV) shares hit a yearly low of $0.67. The stock was down 2.39% on the session.
    • HEXO (NASDAQ:HEXO) shares made a new 52-week low of $0.16 on Tuesday. The stock was down 3.15% for the day.
    • Jianzhi Education Tech (NASDAQ:JZ) shares hit a yearly low of $1.25. The stock was down 2.29% on the session.
    • Camber Energy (AMEX:CEI) shares hit a yearly low of $0.10. The stock was up 2.48% on the session.
    • PAVmed (NASDAQ:PAVM) stock set a new 52-week low of $0.65 on Tuesday, moving down 6.27%.
    • Natural Alternatives Intl (NASDAQ:NAII) stock hit a new 52-week low of $7.37. The stock was up 3.71% on the session.
    • IronNet (NYSE:IRNT) stock hit a yearly low of $0.42. The stock was down 2.26% for the day.
    • Jounce Therapeutics (NASDAQ:JNCE) stock dropped to a yearly low on Tuesday of $0.79. Shares traded up 3.42%.
    • Palatin Techs (AMEX:PTN) stock achieved a new 52-week low on Tuesday morning, hitting $3.85 and moving up 2.33%.
    • Blue Apron Hldgs (NYSE:APRN) stock hit $0.94 on Tuesday morning, setting a new 52-week low for a change of up 2.63%.
    • NextCure (NASDAQ:NXTC) stock set a new 52-week low of $1.33 on Tuesday, moving down 2.17%.
    • Ryvyl (NASDAQ:RVYL) stock dropped to a yearly low on Tuesday of $0.66. Shares traded down 1.91%.
    • NightHawk Biosciences (AMEX:NHWK) shares fell to $1.26 on Tuesday, setting a new 52-week low with a shift of down 2.1%.
    • Hempacco (NASDAQ:HPCO) shares reached a new 52-week low of $1.35 on Tuesday morning, moving down 0.44%.
    • Worksport (NASDAQ:WKSP) stock hit $1.54 on Tuesday morning, setting a new 52-week low for a change of down 1.29%.
    • TuanChe (NASDAQ:TC) stock dropped to a yearly low on Tuesday of $0.97. Shares traded down 2.91%.
    • AIM ImmunoTech (AMEX:AIM) stock drifted down 9.0% on Tuesday morning to hit a new 52-week low of $0.40.
    • eFFECTOR Therapeutics (NASDAQ:EFTR) stock hit $0.43 on Tuesday morning, setting a new 52-week low for a change of down 1.46%.
    • IM Cannabis (NASDAQ:IMCC) shares hit a yearly low of $2.02. The stock was up 1.9% on the session.
    • Vincerx Pharma (NASDAQ:VINC) stock hit $0.67 on Tuesday morning, setting a new 52-week low for a change of down 2.0%.
    • Troika Media Group (NASDAQ:TRKA) stock drifted up 2.36% on Tuesday morning to hit a new 52-week low of $0.15.
    • Cryptyde (NASDAQ:TYDE) shares made a new 52-week low of $0.28 on Tuesday. The stock was down 3.43% for the day.
    • LM Funding America (NASDAQ:LMFA) stock hit a yearly low of $0.70. The stock was down 2.06% for the day.
    • Avenue Therapeutics (NASDAQ:ATXI) stock hit $1.34 on Tuesday morning, setting a new 52-week low for a change of up 3.65%.
    • Nabriva Therapeutics (NASDAQ:NBRV) shares set a new yearly low of $1.83 this morning. The stock was up 0.48% on the session.
    • Intelligent Bio Solutions (NASDAQ:INBS) stock broke to a new 52-week low of $0.34 on Tuesday. Shares of the company traded down 10.16%.
    • Netcapital (NASDAQ:NCPL) stock set a new 52-week low of $1.25 on Tuesday, moving down 6.72%.
    • CohBar (NASDAQ:CWBR) stock dropped to a yearly low on Tuesday of $1.50. Shares traded down 0.66%.
    • Viveve Medical (NASDAQ:VIVE) stock dropped to a yearly low on Tuesday of $0.40. Shares traded down 2.41%.
    • Akerna (NASDAQ:KERN) stock hit a yearly low of $0.85. The stock was up 7.69% for the day.
    • Reshape Lifesciences (NASDAQ:RSLS) shares set a new 52-week low of $0.14. The stock traded up 2.15%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $NAII alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NAII
    $NBRV
    $NCPL
    $NHWK

    CompanyDatePrice TargetRatingAnalyst
    Brookfield Business Partners L.P. Limited Partnership Units
    $BBU
    2/27/2026$44.00Sector Outperform
    CIBC
    Lumen Technologies Inc.
    $LUMN
    2/4/2026Outperform → Mkt Perform
    Raymond James
    Relmada Therapeutics Inc.
    $RLMD
    1/23/2026$8.00Outperform
    Leerink Partners
    Lumentum Holdings Inc.
    $LITE
    1/8/2026$290.00 → $470.00Buy
    Needham
    Instil Bio Inc.
    $TIL
    1/7/2026Buy → Neutral
    H.C. Wainwright
    Instil Bio Inc.
    $TIL
    1/6/2026$7.00Outperform → Neutral
    Robert W. Baird
    Relmada Therapeutics Inc.
    $RLMD
    12/22/2025$69.00Buy
    Jefferies
    Redwire Corporation
    $RDW
    12/19/2025Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $NAII
    $NBRV
    $NCPL
    $NHWK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CIBC initiated coverage on Brookfield Business Partners with a new price target

    CIBC initiated coverage of Brookfield Business Partners with a rating of Sector Outperform and set a new price target of $44.00

    2/27/26 9:41:26 AM ET
    $BBU
    Engineering & Construction
    Consumer Discretionary

    Lumen Technologies downgraded by Raymond James

    Raymond James downgraded Lumen Technologies from Outperform to Mkt Perform

    2/4/26 8:28:23 AM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Leerink Partners resumed coverage on Relmada Therapeutics with a new price target

    Leerink Partners resumed coverage of Relmada Therapeutics with a rating of Outperform and set a new price target of $8.00

    1/23/26 8:21:07 AM ET
    $RLMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NAII
    $NBRV
    $NCPL
    $NHWK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO/Chairman Ledoux Mark A bought $3,528 worth of shares (1,250 units at $2.82), increasing direct ownership by 0.80% to 157,971 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    2/27/26 5:18:48 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    New insider Adlich Steve claimed ownership of 55,000 shares (SEC Form 3)

    3 - Redwire Corp (0001819810) (Issuer)

    2/27/26 4:44:03 PM ET
    $RDW
    Military/Government/Technical
    Industrials

    SEC Form 4 filed by VP, Controller & CAO Kroll Anita J

    4 - TELEPHONE & DATA SYSTEMS INC /DE/ (0001051512) (Issuer)

    2/27/26 4:11:58 PM ET
    $TDS
    Telecommunications Equipment
    Telecommunications

    $NAII
    $NBRV
    $NCPL
    $NHWK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (ORIG-1) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 04/23/2021. Application Category: BLA, Application Number: 761196, Application Classification:

    4/23/21 1:46:03 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NAII
    $NBRV
    $NCPL
    $NHWK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Mach 2 and Beyond: Aerospace Enters Its Biggest Spending Cycle

    Issued on behalf of Starfighters SpaceVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity Insider News Commentary -- Congress approved $839 billion in Pentagon funding for fiscal 2026, $8 billion more than the Department of Defense requested, with billions earmarked for space, missile defense, and advanced aerospace systems[1]. The Pentagon's $152 billion reconciliation spending plan allocates $2.2 billion specifically to accelerate hypersonic defense systems and $5.6 billion for space-based interceptors[2]. Companies positioned across aerospace testing, defense technology, and space infrastructure include Starfighters Space (NYSE-A: FJET), Kratos Defense (NASDAQ:KTOS), V2X (NYSE:VVX), Redwire (NYS

    2/27/26 11:24:00 AM ET
    $FJET
    $KTOS
    $LUNR
    Air Freight/Delivery Services
    Consumer Discretionary
    Military/Government/Technical
    Industrials

    AIM ImmunoTech Reminds Stockholders of March 3, 2026 Expiration Date and Updates Terms of Previously Announced Rights Offering

    OCALA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) – AIM ImmunoTech Inc. ("AIM" or the "Company"), an immuno-pharma company focused on the research and development of its lead product, Ampligen® (rintatolimod), for the treatment of late-stage pancreatic cancer – a lethal and unmet global health problem – today announced updated terms for its previously announced rights offering (the "Rights Offering"). Each subscription right now entitles holders to purchase one unit (the "Units"), each Unit consisting of one share of the Company's Series G Convertible Preferred Stock (the "Preferred Stock"), and 2,000 Class G Common Stock Purchase Warrants to purchase the Compa

    2/27/26 9:00:00 AM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $NAII
    $NBRV
    $NCPL
    $NHWK
    SEC Filings

    View All

    SEC Form S-8 filed by CNS Pharmaceuticals Inc.

    S-8 - CNS Pharmaceuticals, Inc. (0001729427) (Filer)

    2/27/26 5:22:40 PM ET
    $CNSP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Redwire Corporation

    10-K - Redwire Corp (0001819810) (Filer)

    2/27/26 5:15:43 PM ET
    $RDW
    Military/Government/Technical
    Industrials

    SEC Form 6-K filed by Token Cat Limited

    6-K - Token Cat Ltd (0001743340) (Filer)

    2/27/26 4:30:01 PM ET
    $TC
    Real Estate

    $NAII
    $NBRV
    $NCPL
    $NHWK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO/Chairman Ledoux Mark A bought $3,528 worth of shares (1,250 units at $2.82), increasing direct ownership by 0.80% to 157,971 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    2/27/26 5:18:48 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    CEO/Chairman Ledoux Mark A bought $5,399 worth of shares (2,000 units at $2.70), increasing direct ownership by 1% to 156,971 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    2/24/26 9:17:31 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    CEO/Chairman Ledoux Mark A bought $11,604 worth of shares (4,500 units at $2.58), increasing direct ownership by 3% to 154,721 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    2/20/26 6:05:52 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    $NBRV
    $NCPL
    $NHWK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by AIM ImmunoTech Inc.

    SC 13D/A - AIM ImmunoTech Inc. (0000946644) (Subject)

    12/17/24 4:11:23 PM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Xos Inc.

    SC 13D/A - Xos, Inc. (0001819493) (Subject)

    12/9/24 3:57:56 PM ET
    $XOS
    Auto Parts:O.E.M.
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Xos Inc.

    SC 13D/A - Xos, Inc. (0001819493) (Subject)

    12/9/24 3:45:37 PM ET
    $XOS
    Auto Parts:O.E.M.
    Consumer Discretionary

    $NAII
    $NBRV
    $NCPL
    $NHWK
    Leadership Updates

    Live Leadership Updates

    View All

    Lucid Announces Appointment of Neil Marsons as Senior Vice President of Supply Chain

    NEWARK, Calif., Feb. 9, 2026 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ:LCID), maker of the world's most advanced electric vehicles, today announced Neil Marsons has joined the organization as the Senior Vice President of Supply Chain. Bringing more than 20 years of experience to the role, Marsons will be responsible for expanding and strengthening the company's global supply chain, as well as closely partnering across the organization to support production at the company's facilities in Arizona and Saudi Arabia. Previously, Marsons served as the Group Chief Procurement Officer

    2/9/26 10:49:00 AM ET
    $LCID
    Auto Manufacturing
    Industrials

    Cango Inc. Completes Bitcoin Sale to Strengthen Financial Position and Advance AI Transformation

    DALLAS, Feb. 9, 2026 /PRNewswire/ -- Cango Inc. (NYSE:CANG) ("Cango" or the "Company"), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, today announced that, based on a comprehensive assessment of current market conditions and upon approval of the Company's Board of Directors, it completed the sale of 4,451 Bitcoin on the open market during the past weekend, which were settled directly in USDT for aggregate net proceeds of approximately US$305 million in equivalent value. The full amount of the USDT proceeds has been utilized to partially repay a Bitcoin-collateralized loan.

    2/9/26 6:26:00 AM ET
    $CANG
    Computer Software: Prepackaged Software
    Technology

    Lumen Technologies Appoints Jeff Sharritts as Chief Revenue Officer

    Veteran leader to deepen customer relationships, sharpen execution, and scale company's commercial engine in Lumen's next phase of transformation Lumen Technologies (NYSE: LUMN) today announced that Jeff Sharritts has been appointed Executive Vice President and Chief Revenue Officer, effective Feb. 4, 2026. He will report to Lumen CEO Kate Johnson and will lead Lumen's commercial strategy, including the Acceleration and Growth Team, with a focus on deepening customer relationships and driving profitable growth for the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260203640994/en/LUMN) as EVP and Chief Revenue Officer

    2/3/26 4:01:00 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    $NAII
    $NBRV
    $NCPL
    $NHWK
    Financials

    Live finance-specific insights

    View All

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Total Revenues of $148.7 million; Full Year 2025 Total Revenues of $742.9 millionFourth Quarter 2025 Net Loss of $54.6 million and Net Loss Margin of 37%Full Year 2025 Net Income of $52.6 million versus a Net Loss of $190.6 million in the prior yearFull Year 2025 Net Income per diluted share of $0.93 versus a Net Loss per diluted share of $3.60 in the prior yearFull Year 2025 Adjusted Net Income of $86.8 million versus an Adjusted Net Loss of $12.1 million in the prior yearFull Year 2025 Adjusted Net Income per diluted share of $1.53 versus an Adjusted Net Loss per diluted share of $0.23 in the prior yearFull Year 2025 Gross Margin % of 45% and Adjusted Gross Margin % of

    2/26/26 4:05:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Redwire Corporation Reports Fourth Quarter and Full Year 2025 Financial Results, Achieves Top End of 2025 Revenue Guidance Range with Record Contracted Backlog

    Redwire Corporation (NYSE:RDW, "Redwire" or the "Company")), a global leader in space and defense technology solutions, today announced results for its fourth quarter and full year ended December 31, 2025. "2025 marked the transformation of Redwire into an integrated, multi-domain space and defense tech company. This evolution is reflected in our new structure, which we believe will enable us to maintain strong positioning and continue our growth trajectory across both established and rapidly emerging domains," stated Peter Cannito, Chairman and Chief Executive Officer of Redwire. "With continued acceleration in contract awards during the fourth quarter of 2025 and confidence provided by

    2/25/26 4:30:00 PM ET
    $RDW
    Military/Government/Technical
    Industrials

    $NAII
    $NBRV
    $NCPL
    $NHWK
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Stock Movement: Insider Purchase at Motorcar Parts of America Inc. on Jun 17

    Recently, on June 17, 2024, Director Bison Capital Partners Vi, L.P. made a significant move by purchasing $874,000 worth of Motorcar Parts of America Inc. shares. This purchase consisted of 150,000 units at a price of $5.83 per share, marking a substantial increase in direct ownership by 150% to 250,000 units as reported in SEC Form 4. The timing and scale of this insider purchase are noteworthy as it indicates a strong belief in the company's future prospects. Examining the series of insider transactions involving Motorcar Parts of America Inc. insiders, there seem to be interesting patterns emerging. In particular, Ferguson Joseph Edwin, Rankin Jamy P., and Gay Philip all converted optio

    6/18/24 10:09:31 PM ET
    $MPAA
    Auto Parts:O.E.M.
    Consumer Discretionary

    Stock Movement: Insider Purchase at Motorcar Parts of America Inc. on Jun 18

    On June 18, 2024, Director Bison Capital Partners Vi, L.P. bought $116,319 worth of shares (20,300 units at $5.73), increasing their direct ownership by 8% to 270,300 units, as reported in SEC Form 4. This insider purchase indicates a strong show of confidence in the future prospects of Motorcar Parts of America Inc. When analyzing this transaction alongside other recent activities by company insiders, some interesting patterns emerge. Gay Philip converted options into 6,596 shares, increasing his direct ownership by 18% to 42,576 units back on November 16, 2023. This move indicated a bullish sentiment from an insider perspective. However, not all insider activities were positive. Borneo R

    6/18/24 10:06:20 PM ET
    $MPAA
    Auto Parts:O.E.M.
    Consumer Discretionary